Bellicum Pharmaceuticals Stock Forecast, Price & News

Bellicum Pharmaceuticals (NASDAQ:BLCM) Frequently Asked Questions

How has Bellicum Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)?

Bellicum Pharmaceuticals' stock was trading at $7.29 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BLCM shares have decreased by 80.2% and is now trading at $1.44.
View which stocks have been most impacted by COVID-19.

When is Bellicum Pharmaceuticals' next earnings date?

Bellicum Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Tuesday, March 29th 2022.
View our earnings forecast for Bellicum Pharmaceuticals.

How were Bellicum Pharmaceuticals' earnings last quarter?

Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) announced its earnings results on Thursday, November, 4th. The biopharmaceutical company reported $0.07 EPS for the quarter. The biopharmaceutical company had revenue of $5 million for the quarter.
View Bellicum Pharmaceuticals' earnings history.

When did Bellicum Pharmaceuticals' stock split? How did Bellicum Pharmaceuticals' stock split work?

Shares of Bellicum Pharmaceuticals reverse split on the morning of Thursday, February 6th 2020. The 1-10 reverse split was announced on Wednesday, February 5th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, February 5th 2020. An investor that had 100 shares of Bellicum Pharmaceuticals stock prior to the reverse split would have 10 shares after the split.

Who are Bellicum Pharmaceuticals' key executives?

Bellicum Pharmaceuticals' management team includes the following people:

• Richard A. Fair, President, Chief Executive Officer & Director
• Aaron Foster, Senior Vice President & Head-Research
• Joseph Howard Senesac, Vice President-Viral Vector Development

Who are some of Bellicum Pharmaceuticals' key competitors?

Some companies that are related to Bellicum Pharmaceuticals include Gain Therapeutics (GANX), Cocrystal Pharma (COCP), Aravive (ARAV), Cumberland Pharmaceuticals (CPIX), Addex Therapeutics (ADXN), Aprea Therapeutics (APRE), DiaMedica Therapeutics (DMAC), Statera BioPharma (STAB), Moleculin Biotech (MBRX), Odonate Therapeutics (ODT), Aeterna Zentaris (AEZS), IMARA (IMRA), Addex Therapeutics (ADDXF), Stealth BioTherapeutics (MITO) and Elite Pharmaceuticals (ELTP).
View all of BLCM's competitors.

What other stocks do shareholders of Bellicum Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bellicum Pharmaceuticals investors own include Arrowhead Pharmaceuticals (ARWR), Alliance Resource Partners (ARLP), AVEO Pharmaceuticals (AVEO), TransEnterix (TRXC), CyberArk Software (CYBR), AcelRx Pharmaceuticals (ACRX), Gilead Sciences (GILD), Novavax (NVAX), Pfizer (PFE) and Inovio Pharmaceuticals (INO).

When did Bellicum Pharmaceuticals IPO?

(BLCM) raised $101 million in an initial public offering on Thursday, December 18th 2014. The company issued 6,300,000 shares at $15.00-$17.00 per share. Jefferies, Citigroup and Piper Jaffray acted as the underwriters for the IPO and Trout Capital was co-manager.

What is Bellicum Pharmaceuticals' stock symbol?

Bellicum Pharmaceuticals trades on the NASDAQ under the ticker symbol "BLCM."

How do I buy shares of Bellicum Pharmaceuticals?

Shares of BLCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bellicum Pharmaceuticals' stock price today?

One share of BLCM stock can currently be purchased for approximately $1.44.

How much money does Bellicum Pharmaceuticals make?

Bellicum Pharmaceuticals has a market capitalization of $12.09 million and generates $500 thousand in revenue each year. The biopharmaceutical company earns $-7.72 million in net income (profit) each year or ($0.29) on an earnings per share basis.

How many employees does Bellicum Pharmaceuticals have?

Bellicum Pharmaceuticals employs 16 workers across the globe.

What is Bellicum Pharmaceuticals' official website?

The official website for Bellicum Pharmaceuticals is www.bellicum.com.

Where are Bellicum Pharmaceuticals' headquarters?

Bellicum Pharmaceuticals is headquartered at 2130 WEST HOLCOMBE BOULEVARD SUITE 800, HOUSTON TX, 77030.

How can I contact Bellicum Pharmaceuticals?

Bellicum Pharmaceuticals' mailing address is 2130 WEST HOLCOMBE BOULEVARD SUITE 800, HOUSTON TX, 77030. The biopharmaceutical company can be reached via phone at (832) 384-1100 or via email at [email protected].